AnalystsAndy Chen
Andy Chen's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 15%
#761 out of 5116 analysts
Average Return
+64.55%
Win Rate
50%9 out of 18
Risk vs Reward
Poor
Good

Andy Chen's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Alpine Immune Sciences IncALPN
+546.47%$10.05$64.97
2023-10-18 -
2024-05-17
Strong Buy
Zenas Biopharma IncZBIO
+406.92%$7.66$38.83
2025-02-04 -
2025-11-28
Buy
Insmed IncINSM
+175.86%$28.75$79.31
2024-02-15 -
2025-02-14
Buy
Avidity Biosciences IncRNA
+144.21%$29.36$71.70
2025-06-17 -
2025-11-28
Buy
Oruka Therapeutics IncORKA
+111.82%$14.21$30.10
2025-02-04 -
2025-11-28
Buy

Andy Chen Analyst Color

Get additional color on Andy Chen's coverage of popular stocks

Andy Chen's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Verona Pharma PLCVRNA
1Buy$170.00+59.01%Initiates Coverage On
5 months ago
Bridgebio Pharma IncBBIO
1Buy$49.00-31.95%Initiates Coverage On
5 months ago
Avidity Biosciences IncRNA
1Buy$55.00-23.29%Initiates Coverage On
5 months ago
Moonlake ImmunotherapeuticsMLTX
1Buy$61.00+344.28%Upgrades
6 months ago
Intellia Therapeutics IncNTLA
1Buy$21.00+133.59%Upgrades
7 months ago
Oruka Therapeutics IncORKA
1Buy$20.00-33.55%Initiates Coverage On
10 months ago
Vera Therapeutics IncVERA
1Buy$49.00+45.19%Initiates Coverage On
10 months ago
Zenas Biopharma IncZBIO
1Buy$19.00-51.07%Initiates Coverage On
10 months ago
Argenx SeARGX
1Buy$697.00N/AUpgrades
a year ago
Celldex Therapeutics IncCLDX
1Buy$51.00N/AReiterates
a year ago
Kymera Therapeutics IncKYMR
1Buy$65.00N/AUpgrades
a year ago
Roivant Sciences LtdROIV
1Buy$17.00N/AInitiates Coverage On
2 years ago
Immunovant IncIMVT
1Buy$55.00N/AInitiates Coverage On
2 years ago
Insmed IncINSM
1Buy$42.00N/AInitiates Coverage On
2 years ago
Rapt Therapeutics IncRAPT
2Buy$312.00N/AInitiates Coverage On
2 years ago
Alpine Immune Sciences IncALPN
1Strong Buy$18.00N/AInitiates Coverage On
2 years ago
Affimed NvAFMDQ
1Strong Buy$60.00N/AAssumes
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.